Hill-Rom Holdings, Inc. (NYSE: HRC) Stock Competitors & Peer Comparison
See HRC's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for HRC and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HRC | $155.96 | +0.03% | 0 | 41.92 | $3.72 | +0.60% |
| ISRG | $385.13 | +1.90% | 133.2B | 39.21 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.13% |
| BDX | $184.20 | +0.71% | 51.2B | 14.30 | $13.00 | +2.13% |
| RMD | $227.67 | +2.10% | 33.3B | 21.32 | $10.77 | +1.06% |
| MDLN | $33.50 | +2.78% | 27.2B | 23.53 | $1.36 | N/A |
| WST | $361.98 | +1.91% | 25.7B | 42.93 | $8.50 | +0.24% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $90.53 | +0.79% | 15.6B | 12.69 | $7.10 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.13% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
HRC vs ISRG Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ISRG has a market cap of 133.2B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ISRG trades at $385.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ISRG's P/E ratio is 39.21. In terms of profitability, HRC's ROE is +0.14%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, HRC is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
HRC vs BDXA Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas BDXA's P/E ratio is 45.70. In terms of profitability, HRC's ROE is +0.14%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, HRC is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for HRC.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
HRC vs BDX Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, BDX has a market cap of 51.2B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while BDX trades at $184.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas BDX's P/E ratio is 14.30. In terms of profitability, HRC's ROE is +0.14%, compared to BDX's ROE of +0.04%. Regarding short-term risk, HRC is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for HRC.Check BDX's competition here
ResMed Inc. (NYSE: RMD)
HRC vs RMD Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, RMD has a market cap of 33.3B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while RMD trades at $227.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas RMD's P/E ratio is 21.32. In terms of profitability, HRC's ROE is +0.14%, compared to RMD's ROE of +0.24%. Regarding short-term risk, HRC is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for HRC.Check RMD's competition here
Medline Inc. (NASDAQ: MDLN)
HRC vs MDLN Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, MDLN has a market cap of 27.2B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while MDLN trades at $33.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas MDLN's P/E ratio is 23.53. In terms of profitability, HRC's ROE is +0.14%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, HRC is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for HRC.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
HRC vs WST Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, WST has a market cap of 25.7B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while WST trades at $361.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas WST's P/E ratio is 42.93. In terms of profitability, HRC's ROE is +0.14%, compared to WST's ROE of +0.19%. Regarding short-term risk, HRC is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for HRC.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
HRC vs HOLX Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas HOLX's P/E ratio is 31.54. In terms of profitability, HRC's ROE is +0.14%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, HRC is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for HRC.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
HRC vs SOLV Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, SOLV has a market cap of 15.6B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while SOLV trades at $90.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas SOLV's P/E ratio is 12.69. In terms of profitability, HRC's ROE is +0.14%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, HRC is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for HRC.Check SOLV's competition here
Becton, Dickinson and Company (NYSE: BDXB)
HRC vs BDXB Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas BDXB's P/E ratio is 7.60. In terms of profitability, HRC's ROE is +0.14%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, HRC is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for HRC.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
HRC vs BAX Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, BAX has a market cap of 12.3B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while BAX trades at $23.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas BAX's P/E ratio is 11.39. In terms of profitability, HRC's ROE is +0.14%, compared to BAX's ROE of -0.17%. Regarding short-term risk, HRC is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for HRC.Check BAX's competition here
Avantor, Inc. (NYSE: AVTR)
HRC vs AVTR Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, AVTR has a market cap of 10.4B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while AVTR trades at $15.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas AVTR's P/E ratio is 18.15. In terms of profitability, HRC's ROE is +0.14%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, HRC is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for HRC.Check AVTR's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
HRC vs COO Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, COO has a market cap of 10.4B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while COO trades at $54.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas COO's P/E ratio is 11.68. In terms of profitability, HRC's ROE is +0.14%, compared to COO's ROE of +0.07%. Regarding short-term risk, HRC is less volatile compared to COO. This indicates lower risk in terms of short-term price fluctuations for HRC.Check COO's competition here
Repligen Corporation (NASDAQ: RGEN)
HRC vs RGEN Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, RGEN has a market cap of 9.9B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while RGEN trades at $174.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas RGEN's P/E ratio is 97.07. In terms of profitability, HRC's ROE is +0.14%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, HRC is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for HRC.Check RGEN's competition here
AptarGroup, Inc. (NYSE: ATR)
HRC vs ATR Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ATR has a market cap of 8B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ATR trades at $125.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ATR's P/E ratio is 21.79. In terms of profitability, HRC's ROE is +0.14%, compared to ATR's ROE of +0.14%. Regarding short-term risk, HRC is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
HRC vs BLCO Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while BLCO trades at $17.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas BLCO's P/E ratio is 26.52. In terms of profitability, HRC's ROE is +0.14%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, HRC is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for HRC.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
HRC vs STVN Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while STVN trades at $21.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas STVN's P/E ratio is 32.57. In terms of profitability, HRC's ROE is +0.14%, compared to STVN's ROE of +0.09%. Regarding short-term risk, HRC is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for HRC.Check STVN's competition here
Teleflex Incorporated (NYSE: TFX)
HRC vs TFX Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, TFX has a market cap of 5.7B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while TFX trades at $129.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas TFX's P/E ratio is 14.75. In terms of profitability, HRC's ROE is +0.14%, compared to TFX's ROE of -0.32%. Regarding short-term risk, HRC is less volatile compared to TFX. This indicates lower risk in terms of short-term price fluctuations for HRC.Check TFX's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
HRC vs MMSI Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, MMSI has a market cap of 5.1B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while MMSI trades at $86.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas MMSI's P/E ratio is 22.04. In terms of profitability, HRC's ROE is +0.14%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, HRC is less volatile compared to MMSI. This indicates lower risk in terms of short-term price fluctuations for HRC.Check MMSI's competition here
Envista Holdings Corp (NYSE: NVST)
HRC vs NVST Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, NVST has a market cap of 4B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while NVST trades at $25.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas NVST's P/E ratio is 16.85. In terms of profitability, HRC's ROE is +0.14%, compared to NVST's ROE of +0.04%. Regarding short-term risk, HRC is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for HRC.Check NVST's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
HRC vs ICUI Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ICUI trades at $158.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ICUI's P/E ratio is 19.46. In terms of profitability, HRC's ROE is +0.14%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, HRC is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ICUI's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
HRC vs PLSE Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, PLSE has a market cap of 3.8B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while PLSE trades at $49.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas PLSE's P/E ratio is -46.78. In terms of profitability, HRC's ROE is +0.14%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, HRC is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for HRC.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
HRC vs ATRC Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ATRC has a market cap of 2.9B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ATRC trades at $56.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ATRC's P/E ratio is 1745.96. In terms of profitability, HRC's ROE is +0.14%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, HRC is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
HRC vs XRAY Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, XRAY has a market cap of 2B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while XRAY trades at $10.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas XRAY's P/E ratio is 6.87. In terms of profitability, HRC's ROE is +0.14%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, HRC is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for HRC.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
HRC vs LMAT Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, LMAT has a market cap of 1.8B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while LMAT trades at $80.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas LMAT's P/E ratio is 29.69. In terms of profitability, HRC's ROE is +0.14%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, HRC is less volatile compared to LMAT. This indicates lower risk in terms of short-term price fluctuations for HRC.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
HRC vs BLFS Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while BLFS trades at $36.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas BLFS's P/E ratio is -172.18. In terms of profitability, HRC's ROE is +0.14%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, HRC is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for HRC.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
HRC vs AZTA Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, AZTA has a market cap of 1.5B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while AZTA trades at $33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas AZTA's P/E ratio is 78.64. In terms of profitability, HRC's ROE is +0.14%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, HRC is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for HRC.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
HRC vs KMTS Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, KMTS has a market cap of 1.5B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while KMTS trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas KMTS's P/E ratio is -9.50. In terms of profitability, HRC's ROE is +0.14%, compared to KMTS's ROE of -0.64%. Regarding short-term risk, HRC is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for HRC.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
HRC vs STAA Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, STAA has a market cap of 1.1B. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while STAA trades at $22.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas STAA's P/E ratio is 39.38. In terms of profitability, HRC's ROE is +0.14%, compared to STAA's ROE of +0.01%. Regarding short-term risk, HRC is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for HRC.Check STAA's competition here
Atrion Corporation (NASDAQ: ATRI)
HRC vs ATRI Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ATRI's P/E ratio is 64.50. In terms of profitability, HRC's ROE is +0.14%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, HRC is less volatile compared to ATRI. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
HRC vs ANGO Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ANGO has a market cap of 648.1M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ANGO trades at $15.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ANGO's P/E ratio is -40.21. In terms of profitability, HRC's ROE is +0.14%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, HRC is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ANGO's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
HRC vs SMTI Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, SMTI has a market cap of 322.8M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while SMTI trades at $35.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas SMTI's P/E ratio is -585.17. In terms of profitability, HRC's ROE is +0.14%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, HRC is less volatile compared to SMTI. This indicates lower risk in terms of short-term price fluctuations for HRC.Check SMTI's competition here
Embecta Corp. (NASDAQ: EMBC)
HRC vs EMBC Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, EMBC has a market cap of 302M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while EMBC trades at $5.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas EMBC's P/E ratio is 1.96. In terms of profitability, HRC's ROE is +0.14%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, HRC is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for HRC.Check EMBC's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
HRC vs NNNN Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, NNNN has a market cap of 241.8M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while NNNN trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas NNNN's P/E ratio is 79.62. In terms of profitability, HRC's ROE is +0.14%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, HRC is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for HRC.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
HRC vs OSUR Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, OSUR has a market cap of 238.2M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while OSUR trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas OSUR's P/E ratio is -5.01. In terms of profitability, HRC's ROE is +0.14%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, HRC is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for HRC.Check OSUR's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
HRC vs UTMD Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, UTMD has a market cap of 237.6M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while UTMD trades at $74.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas UTMD's P/E ratio is 22.08. In terms of profitability, HRC's ROE is +0.14%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, HRC is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for HRC.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
HRC vs PDEX Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, PDEX has a market cap of 213.6M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while PDEX trades at $72.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas PDEX's P/E ratio is 16.20. In terms of profitability, HRC's ROE is +0.14%, compared to PDEX's ROE of +0.31%. Regarding short-term risk, HRC is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for HRC.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
HRC vs KRMD Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, KRMD has a market cap of 145.1M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while KRMD trades at $3.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas KRMD's P/E ratio is -79.00. In terms of profitability, HRC's ROE is +0.14%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, HRC is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for HRC.Check KRMD's competition here
Stereotaxis, Inc. (AMEX: STXS)
HRC vs STXS Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, STXS has a market cap of 129.3M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while STXS trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas STXS's P/E ratio is -7.76. In terms of profitability, HRC's ROE is +0.14%, compared to STXS's ROE of -1.33%. Regarding short-term risk, HRC is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for HRC.Check STXS's competition here
Daxor Corporation (NASDAQ: DXR)
HRC vs DXR Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, DXR has a market cap of 68M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while DXR trades at $11.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas DXR's P/E ratio is 9.47. In terms of profitability, HRC's ROE is +0.14%, compared to DXR's ROE of +0.13%. Regarding short-term risk, HRC is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for HRC.Check DXR's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
HRC vs AKYA Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas AKYA's P/E ratio is -1.34. In terms of profitability, HRC's ROE is +0.14%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, HRC is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for HRC.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
HRC vs STSS Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas STSS's P/E ratio is -0.02. In terms of profitability, HRC's ROE is +0.14%, compared to STSS's ROE of -1.54%. Regarding short-term risk, HRC is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for HRC.Check STSS's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
HRC vs OMIC Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas OMIC's P/E ratio is -0.58. In terms of profitability, HRC's ROE is +0.14%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, HRC is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for HRC.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
HRC vs IGAP Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas IGAP's P/E ratio is -10.52. In terms of profitability, HRC's ROE is +0.14%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, HRC is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for HRC.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
HRC vs NEPH Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, NEPH has a market cap of 46.6M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while NEPH trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas NEPH's P/E ratio is 71.50. In terms of profitability, HRC's ROE is +0.14%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, HRC is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for HRC.Check NEPH's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
HRC vs POCI Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, POCI has a market cap of 46.1M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while POCI trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas POCI's P/E ratio is -6.68. In terms of profitability, HRC's ROE is +0.14%, compared to POCI's ROE of -0.37%. Regarding short-term risk, HRC is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for HRC.Check POCI's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
HRC vs HBIO Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, HBIO has a market cap of 36M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while HBIO trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas HBIO's P/E ratio is -22.17. In terms of profitability, HRC's ROE is +0.14%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, HRC is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for HRC.Check HBIO's competition here
Milestone Scientific Inc. (AMEX: MLSS)
HRC vs MLSS Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, MLSS has a market cap of 35.5M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while MLSS trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas MLSS's P/E ratio is -8.02. In terms of profitability, HRC's ROE is +0.14%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, HRC is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for HRC.Check MLSS's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
HRC vs SDC Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas SDC's P/E ratio is -0.03. In terms of profitability, HRC's ROE is +0.14%, compared to SDC's ROE of -1.96%. Regarding short-term risk, HRC is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for HRC.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
HRC vs IVC Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas IVC's P/E ratio is -0.79. In terms of profitability, HRC's ROE is +0.14%, compared to IVC's ROE of -0.46%. Regarding short-term risk, HRC is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for HRC.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
HRC vs RVP Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while RVP trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas RVP's P/E ratio is -5.67. In terms of profitability, HRC's ROE is +0.14%, compared to RVP's ROE of -0.05%. Regarding short-term risk, HRC is less volatile compared to RVP. This indicates lower risk in terms of short-term price fluctuations for HRC.Check RVP's competition here
Bionano Genomics, Inc. (NASDAQ: BNGO)
HRC vs BNGO Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, BNGO has a market cap of 17.9M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while BNGO trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas BNGO's P/E ratio is -0.36. In terms of profitability, HRC's ROE is +0.14%, compared to BNGO's ROE of -0.79%. Regarding short-term risk, HRC is less volatile compared to BNGO. This indicates lower risk in terms of short-term price fluctuations for HRC.Check BNGO's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
HRC vs ZJYL Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ZJYL has a market cap of 15.6M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ZJYL trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ZJYL's P/E ratio is 13.61. In terms of profitability, HRC's ROE is +0.14%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, HRC is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ZJYL's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
HRC vs RGNT Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, RGNT has a market cap of 12.6M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while RGNT trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas RGNT's P/E ratio is -0.07. In terms of profitability, HRC's ROE is +0.14%, compared to RGNT's ROE of N/A. Regarding short-term risk, HRC is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for HRC.Check RGNT's competition here
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (NASDAQ: CUPR)
HRC vs CUPR Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, CUPR has a market cap of 7.9M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while CUPR trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas CUPR's P/E ratio is -2.12. In terms of profitability, HRC's ROE is +0.14%, compared to CUPR's ROE of -15.69%. Regarding short-term risk, HRC is less volatile compared to CUPR. This indicates lower risk in terms of short-term price fluctuations for HRC.Check CUPR's competition here
Femasys Inc. (NASDAQ: FEMY)
HRC vs FEMY Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, FEMY has a market cap of 7.7M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while FEMY trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas FEMY's P/E ratio is -0.57. In terms of profitability, HRC's ROE is +0.14%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, HRC is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for HRC.Check FEMY's competition here
Lucyd, Inc (NASDAQ: LUCY)
HRC vs LUCY Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, LUCY has a market cap of 5.2M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while LUCY trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas LUCY's P/E ratio is -0.49. In terms of profitability, HRC's ROE is +0.14%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, HRC is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for HRC.Check LUCY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
HRC vs NSTG Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas NSTG's P/E ratio is -0.03. In terms of profitability, HRC's ROE is +0.14%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, HRC is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for HRC.Check NSTG's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
HRC vs POAI Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas POAI's P/E ratio is -0.03. In terms of profitability, HRC's ROE is +0.14%, compared to POAI's ROE of -21.19%. Regarding short-term risk, HRC is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for HRC.Check POAI's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
HRC vs MHUA Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas MHUA's P/E ratio is 0.25. In terms of profitability, HRC's ROE is +0.14%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, HRC is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for HRC.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
HRC vs NXGL Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, NXGL has a market cap of 2.4M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while NXGL trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas NXGL's P/E ratio is -0.40. In terms of profitability, HRC's ROE is +0.14%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, HRC is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for HRC.Check NXGL's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
HRC vs GMVD Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas GMVD's P/E ratio is -0.01. In terms of profitability, HRC's ROE is +0.14%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, HRC is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for HRC.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
HRC vs GMVDW Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas GMVDW's P/E ratio is N/A. In terms of profitability, HRC's ROE is +0.14%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, HRC is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for HRC.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
HRC vs AVGR Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas AVGR's P/E ratio is -0.05. In terms of profitability, HRC's ROE is +0.14%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, HRC is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for HRC.Check AVGR's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
HRC vs NXGLW Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, NXGLW has a market cap of 1.2M. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while NXGLW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas NXGLW's P/E ratio is -0.02. In terms of profitability, HRC's ROE is +0.14%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, HRC is less volatile compared to NXGLW. This indicates lower risk in terms of short-term price fluctuations for HRC.Check NXGLW's competition here
Lucyd, Inc (NASDAQ: LUCYW)
HRC vs LUCYW Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas LUCYW's P/E ratio is N/A. In terms of profitability, HRC's ROE is +0.14%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, HRC is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for HRC.Check LUCYW's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
HRC vs ATRS Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ATRS has a market cap of 0. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ATRS's P/E ratio is 14.95. In terms of profitability, HRC's ROE is +0.14%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, HRC is less volatile compared to ATRS. This indicates lower risk in terms of short-term price fluctuations for HRC.Check ATRS's competition here
Apria, Inc. (NASDAQ: APR)
HRC vs APR Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, APR has a market cap of 0. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas APR's P/E ratio is 22.59. In terms of profitability, HRC's ROE is +0.14%, compared to APR's ROE of +9.81%. Regarding short-term risk, HRC is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for HRC.Check APR's competition here
Analogic Corporation (NASDAQ: ALOG)
HRC vs ALOG Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, ALOG has a market cap of 0. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas ALOG's P/E ratio is 40.93. In terms of profitability, HRC's ROE is +0.14%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, HRC is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for HRC.Check ALOG's competition here
Invuity, Inc. (NASDAQ: IVTY)
HRC vs IVTY Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, IVTY has a market cap of 0. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas IVTY's P/E ratio is -3.80. In terms of profitability, HRC's ROE is +0.14%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, HRC is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for HRC.Check IVTY's competition here
IntriCon Corporation (NASDAQ: IIN)
HRC vs IIN Comparison September 2026
Hill-Rom Holdings, Inc. (NYSE: HRC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HRC stands at 0. In comparison, IIN has a market cap of 0. Regarding current trading prices, HRC is priced at $155.96 on the NYSE, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HRC currently has a P/E ratio of 41.92, whereas IIN's P/E ratio is 226.45. In terms of profitability, HRC's ROE is +0.14%, compared to IIN's ROE of -0.00%. Regarding short-term risk, HRC is similarly volatile compared to IIN. This indicates similar risk in terms of short-term price fluctuations for HRC.Check IIN's competition here